Serum level of soluble CD30 correlates with the aggressiveness of adult T‐cell leukemia/lymphoma

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Science

• Publication date

  2005-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2005.00106.xPMID 16271075PMCID PMC11158340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD30 Is Involved in Inhibition of T-Cell Proliferation by Hodgkin’s Reed-Sternberg Cells 1

  2004cited by this paper
• Hodgkin's disease: Establishment and characterization of four in vitro cell lines

  2004cited by this paper
• CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism.

  2004cited by this paper
• Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30

  2002cited by this paper
• p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.

  2000cited by this paper
• Constitutive Activation Of Nf- κ B In Primary Adult T-cell Leukemia Cells

  1999cited by this paper
• Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells.

  1999cited by this paper
• Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.

  1998cited by this paper
• CD30: expression and function in health and disease.

  1998cited by this paper
• Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.

  1998cited by this paper
• CD30 ligand in lymphoma patients with CD30+ tumors.

  1997cited by this paper
• Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins.

  1997cited by this paper
• Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice.

  1996cited by this paper
• Adult T-cell leukemia in Japan.

  1996cited by this paper
• An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support.

  1996cited by this paper
• CD30 (Ki‐1) expression in adult T‐cell leukaemia/lymphoma is associated with distinctive immunohistological and clinical characteristics

  1995cited by this paper
• A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction.

  1994cited by this paper
• Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines.

  1994cited by this paper
• CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.

  1993cited by this paper
• Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma

  1991cited by this paper
• Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T‐cell leukemia and infectious mononucleosis

  1990cited by this paper
• Ki‐1 (CD30) antigen is released by Ki‐1‐positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki‐1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme‐linked immunosorbent assay

  1989cited by this paper
• A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene

  1988cited by this paper
• Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease.

  1988cited by this paper
• A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene.

  1988cited by this paper
• A proposal for smoldering adult T-cell leukemia--diversity in clinical pictures of adult T-cell leukemia--.

  1983cited by this paper
• Type C Virus-Producing Cell Lines Derived from Adult T Cell Leukemia

  1982cited by this paper
• Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies.

  1981cited by this paper
• Hodgkin's disease: establishment and characterization of four in vitro cell lies.

  1981cited by this paper
• Adult T-cell leukemia: clinical and hematologic features of 16 cases.

  1977cited by this paper

• Extracellular CD30 Regulates Brentuximab Vedotin-Induced Cell Death in an Adult T-Cell Leukemia Cell Line.

  2025cites this paper
• Engineering TAG-72 and CD30 CAR-T Cells for T Cell Malignancies

  2025cites this paper
• CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma

  2023cites this paper
• Immune dysregulation as a leading principle for lymphoma development in diverse immunological backgrounds.

  2023cites this paper
• Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma

  2022cites this paper
• Human oncogenic viruses: an overview of protein biomarkers in viral cancers and their potential use in clinics

  2022cites this paper
• Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy

  2020cites this paper
• Novel targeted therapies of T cell lymphomas

  2020cites this paper
• Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL.

  2020cites this paper
• Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis

  2019cites this paper
• Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma Treatment

  2019cites this paper
• CD30 Characterizes Polylobated Lymphocytes and Disease Progression in HTLV-1–Infected Individuals

  2018cites this paper
• Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines.

  2018cites this paper
• Influence of immunosuppressive drugs on the CD30 molecule in kidney transplanted patients.

  2018cites this paper
• Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.

  2018cites this paper
• Human T-cell lymphotropic virus type 1 and its oncogenesis

  2017cites this paper
• Étude clinique et histologique de l’expression du CD30 dans les leucémies et lymphomes liés au virus HTLV-1, et utilisation de l’anticorps monoclonal conjugué anti-CD30 : Brentuximab Vedotin

  2017cites this paper
• Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma.

  2017cites this paper
• Efficiency of AUY922 in mice with adult T-cell leukemia/lymphoma

  2016cites this paper
• Plasma Soluble CD 30 as a Possible Marker of Adult T-cell Leukemia in HTLV-1 Carriers : a Nested Case-Control Study

  2016cites this paper
• Peridinin, a carotenoid, inhibits proliferation and survival of HTLV-1-infected T-cell lines.

  2016cites this paper
• Plasma Soluble CD30 as a Possible Marker of Adult T-cell Leukemia in HTLV-1 Carriers: a Nested Case-Control Study.

  2016cites this paper
• Soluble CD30 and Risk of Adult T-Cell Leukemia in HTLV-1 Carriers

  2016cites this paper
• Serum Soluble CD25 and CD30 Levels as a Biomarker in Adult T-Cell Leukemia/Lymphoma Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

  2015cites this paper
• Serum Soluble CD30 Levels to Detect Activation and Aggression Status of Adult T-Cell Leukemia/Lymphoma Cells

  2015cites this paper
• My Views and Thoughts on Translational Medicine

  2015cites this paper
• Clinical Value of Serum Soluble CD 30 Levels in Adult T-Cell Leukemia / Lymphoma

  2015cites this paper
• Shedding by ADAM10 and ADAM17 is associated with progression of adult T-cell leukemia/lymphoma

  2015cites this paper
• My Views and Thoughts on Translational Medicine

  2015cites this paper
• CD30+ Cells in Lung of Indolent Type Adult T-Cell Leukemia/Lymphoma and Elevated Serum Levels of Soluble CD30 Associated with Acute Crisis and Relapse of Disease

  2014cites this paper
• CD25+, CD30+Adult T-Cell Leukemia/Lymphoma cells, Virus-Infected Cells or Regulatory T-Cells?

  2014cites this paper
• Clinical Value of Serum Soluble CD30 Levels in Adult T-Cell Leukemia/Lymphoma

  2014cites this paper
• A Lack of Cellular Senescence, Formation of Microenvironment, and Role of Soluble CD30 in Development of Adult T-Cell Leukemia/Lymphoma

  2014cites this paper
• Clinical Value of Serum Soluble CD30 Levels in Adult T-Cell Leukemia/

  2014cites this paper
• Soluble CD30 and peripheral blood or pulmonary involvement of adult T-cell leukemia/lymphoma

  2014cites this paper
• CD30 in systemic mastocytosis.

  2014cites this paper
• What is the Role of Soluble Cytokine Receptors in Adult T-cell Leukemia/ Lymphoma?

  2014cites this paper
• Human Retroviruses and Soluble CD30 Levels of Patients

  2014cites this paper
• How to treat Adult T-cell leukemia

  2013cites this paper
• Soluble CD 30 : A Possible Serum Tumor Marker for Primary Effusion Lymphoma

  2012cites this paper
• Soluble CD30: a possible serum tumor marker for primary effusion lymphoma.

  2012cites this paper
• Alloantigen-stimulated induction and release of CD30 in patients with end-stage renal failure.

  2012cites this paper
• The 15th International Conference on Human Retroviruses: HTLV and Related Viruses

  2011cites this paper
• Elderly ATL patients in ageing society of Japan

  2011cites this paper
• Proteins function for anti-senescence and monoclonal proliferation of ATL cells

  2011influential citation
• The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy

  2011cites this paper
• A practical approach to the flow cytometric detection and diagnosis of T-cell lymphoproliferative disorders.

  2010cites this paper
• Susceptibility of human T‐cell leukemia virus type I‐infected cells to humanized anti‐CD30 monoclonal antibodies in vitro and in vivo

  2010cites this paper
• A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantation.

  2010cites this paper
• Development and Validation of a Fluorescent Microsphere Immunoassay for Soluble CD30 Testing

  2009cites this paper
• Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-κB signal pathway

  2007cites this paper
• Increased Serum Levels of Soluble CD30 in Patients with Common Variable Immunodeficiency and Its Clinical Implications

  2007cites this paper
• Soluble CD30 serum level--an adequate marker for allograft rejection of solid organs?

  2007cites this paper